赵明威. 让临床研究走向SCI[J]. 中华眼视光学与视觉科学杂志, 2015, 17(6): 321-322.
Zhao Mingwei. Take clinical study to SCI. Chinese Journal of Optometry Ophthalmology and Visual science, 2015, 17(6): 321-322. DOI: 10.3760/cma.j.issn.1674-845X.2015.06.001
Zhao M, Zhang F, Chen Y, et al. A 50% vs. 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial[J]. JAMA Ophthalmol,2015,133(3):333-340.
[2]
Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dosage of verteporfin[J]. Retina,2009,29(8):1155-1161.
[3]
Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial[J]. Ophthalmology,2008,115(10):1756-1765.